This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hallak, L. K.
Right arrow Articles by Peeples, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hallak, L. K.
Right arrow Articles by Peeples, M. E.

 Previous Article  |  Next Article 

Journal of Virology, November 2000, p. 10508-10513, Vol. 74, No. 22
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Glycosaminoglycan Sulfation Requirements for Respiratory Syncytial Virus Infection

Louay K. Hallak,1 Dorothe Spillmann,2 Peter L. Collins,3 and Mark E. Peeples1,*

Department of Immunology/Microbiology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 606121; Department of Medical Biochemistry and Microbiology, Section for Medical Biochemistry, The Biomedical Center, SE-751 23 Uppsala, Sweden2; and Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-07203

Received 24 May 2000/Accepted 15 August 2000

Glycosaminoglycans (GAGs) on the surface of cultured cells are important in the first step of efficient respiratory syncytial virus (RSV) infection. We evaluated the importance of sulfation, the major biosynthetic modification of GAGs, using an improved recombinant green fluorescent protein-expressing RSV (rgRSV) to assay infection. Pretreatment of HEp-2 cells with 50 mM sodium chlorate, a selective inhibitor of sulfation, for 48 h prior to inoculation reduced the efficiency of rgRSV infection to 40%. Infection of a CHO mutant cell line deficient in N-sulfation was three times less efficient than infection of the parental CHO cell line, indicating that N-sulfation is important. In contrast, infection of a cell line deficient in 2-O-sulfation was as efficient as infection of the parental cell line, indicating that 2-O-sulfation is not required for RSV infection. Incubating RSV with the purified soluble heparin, the prototype GAG, before inoculation had previously been shown to neutralize its infectivity. Here we tested chemically modified heparin chains that lack their N-, C6-O-, or C2-O-sulfate groups. Only heparin chains lacking the N-sulfate group lost the ability to neutralize infection, confirming that N-sulfation, but not C6-O- or C2-O-sulfation, is important for RSV infection. Analysis of heparin fragments identified the 10-saccharide chain as the minimum size that can neutralize RSV infectivity. Taken together, these results show that, while sulfate modification is important for the ability of GAGs to mediate RSV infection, only certain sulfate groups are required. This specificity indicates that the role of cell surface GAGs in RSV infection is not based on a simple charge interaction between the virus and sulfate groups but instead involves a specific GAG structural configuration that includes N-sulfate and a minimum of 10 saccharide subunits. These elements, in addition to iduronic acid demonstrated previously (L. K. Hallak, P. L. Collins, W. Knudson, and M. E. Peeples, Virology 271:264-275, 2000), partially define cell surface molecules important for RSV infection of cultured cells.

* Corresponding author. Mailing address: Department of Immunology/Microbiology, Rush-Presbyterian-St. Luke's Medical Center, 1653 W. Congress Parkway, Chicago, IL 60612. Phone: (312) 942-8736. Fax: (312) 942-2808. E-mail: mpeeples{at}rush.edu.

Journal of Virology, November 2000, p. 10508-10513, Vol. 74, No. 22
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Kwilas, S., Liesman, R. M., Zhang, L., Walsh, E., Pickles, R. J., Peeples, M. E. (2009). Respiratory Syncytial Virus Grown in Vero Cells Contains a Truncated Attachment Protein That Alters Its Infectivity and Dependence on Glycosaminoglycans. J. Virol. 83: 10710-10718 [Abstract] [Full Text]  
  • Dyer, K. D., Percopo, C. M., Fischer, E. R., Gabryszewski, S. J., Rosenberg, H. F. (2009). Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6. Blood 114: 2649-2656 [Abstract] [Full Text]  
  • Groskreutz, D. J., Monick, M. M., Babor, E. C., Nyunoya, T., Varga, S. M., Look, D. C., Hunninghake, G. W. (2009). Cigarette Smoke Alters Respiratory Syncytial Virus-Induced Apoptosis and Replication. Am. J. Respir. Cell Mol. Bio. 41: 189-198 [Abstract] [Full Text]  
  • de Graaf, M., Schrauwen, E. J. A., Herfst, S., van Amerongen, G., Osterhaus, A. D. M. E., Fouchier, R. A. M. (2009). Fusion protein is the main determinant of metapneumovirus host tropism. J. Gen. Virol. 90: 1408-1416 [Abstract] [Full Text]  
  • Wang, H, Su, Z, Schwarze, J (2009). Healthy but not RSV-infected lung epithelial cells profoundly inhibit T cell activation. Thorax 64: 283-290 [Abstract] [Full Text]  
  • Thammawat, S., Sadlon, T. A., Hallsworth, P. G., Gordon, D. L. (2008). Role of Cellular Glycosaminoglycans and Charged Regions of Viral G Protein in Human Metapneumovirus Infection. J. Virol. 82: 11767-11774 [Abstract] [Full Text]  
  • Utley, T. J., Ducharme, N. A., Varthakavi, V., Shepherd, B. E., Santangelo, P. J., Lindquist, M. E., Goldenring, J. R., Crowe, J. E. Jr. (2008). Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc. Natl. Acad. Sci. USA 105: 10209-10214 [Abstract] [Full Text]  
  • Collins, P. L., Graham, B. S. (2008). Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis. J. Virol. 82: 2040-2055 [Full Text]  
  • Chapman, J., Abbott, E., Alber, D. G., Baxter, R. C., Bithell, S. K., Henderson, E. A., Carter, M. C., Chambers, P., Chubb, A., Cockerill, G. S., Collins, P. L., Dowdell, V. C. L., Keegan, S. J., Kelsey, R. D., Lockyer, M. J., Luongo, C., Najarro, P., Pickles, R. J., Simmonds, M., Taylor, D., Tyms, S., Wilson, L. J., Powell, K. L. (2007). RSV604, a Novel Inhibitor of Respiratory Syncytial Virus Replication. Antimicrob. Agents Chemother. 51: 3346-3353 [Abstract] [Full Text]  
  • Kolokoltsov, A. A., Deniger, D., Fleming, E. H., Roberts, N. J. Jr., Karpilow, J. M., Davey, R. A. (2007). Small Interfering RNA Profiling Reveals Key Role of Clathrin-Mediated Endocytosis and Early Endosome Formation for Infection by Respiratory Syncytial Virus. J. Virol. 81: 7786-7800 [Abstract] [Full Text]  
  • Bitko, V., Shulyayeva, O., Mazumder, B., Musiyenko, A., Ramaswamy, M., Look, D. C., Barik, S. (2007). Nonstructural Proteins of Respiratory Syncytial Virus Suppress Premature Apoptosis by an NF-{kappa}B-Dependent, Interferon-Independent Mechanism and Facilitate Virus Growth. J. Virol. 81: 1786-1795 [Abstract] [Full Text]  
  • Crim, R. L., Audet, S. A., Feldman, S. A., Mostowski, H. S., Beeler, J. A. (2007). Identification of Linear Heparin-Binding Peptides Derived from Human Respiratory Syncytial Virus Fusion Glycoprotein That Inhibit Infectivity. J. Virol. 81: 261-271 [Abstract] [Full Text]  
  • Moore, P. E., Cunningham, G., Calder, M. M., DeMatteo, A. D. Jr., Peeples, M. E., Summar, M. L., Peebles, R. S. Jr. (2006). Respiratory Syncytial Virus Infection Reduces beta2-Adrenergic Responses in Human Airway Smooth Muscle. Am. J. Respir. Cell Mol. Bio. 35: 559-564 [Abstract] [Full Text]  
  • Barth, H., Schnober, E. K., Zhang, F., Linhardt, R. J., Depla, E., Boson, B., Cosset, F.-L., Patel, A. H., Blum, H. E., Baumert, T. F. (2006). Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction. J. Virol. 80: 10579-10590 [Abstract] [Full Text]  
  • Chi, B., Dickensheets, H. L., Spann, K. M., Alston, M. A., Luongo, C., Dumoutier, L., Huang, J., Renauld, J.-C., Kotenko, S. V., Roederer, M., Beeler, J. A., Donnelly, R. P., Collins, P. L., Rabin, R. L. (2006). Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus.. J. Virol. 80: 5032-5040 [Abstract] [Full Text]  
  • Guerrero-Plata, A., Casola, A., Suarez, G., Yu, X., Spetch, L., Peeples, M. E., Garofalo, R. P. (2006). Differential Response of Dendritic Cells to Human Metapneumovirus and Respiratory Syncytial Virus. Am. J. Respir. Cell Mol. Bio. 34: 320-329 [Abstract] [Full Text]  
  • Vlasak, M., Goesler, I., Blaas, D. (2005). Human Rhinovirus Type 89 Variants Use Heparan Sulfate Proteoglycan for Cell Attachment. J. Virol. 79: 5963-5970 [Abstract] [Full Text]  
  • Zhang, L., Bukreyev, A., Thompson, C. I., Watson, B., Peeples, M. E., Collins, P. L., Pickles, R. J. (2005). Infection of Ciliated Cells by Human Parainfluenza Virus Type 3 in an In Vitro Model of Human Airway Epithelium. J. Virol. 79: 1113-1124 [Abstract] [Full Text]  
  • Fayzulin, R., Gorchakov, R., Petrakova, O., Volkova, E., Frolov, I. (2005). Sindbis Virus with a Tricomponent Genome. J. Virol. 79: 637-643 [Abstract] [Full Text]  
  • San-Juan-Vergara, H., Peeples, M. E., Lockey, R. F., Mohapatra, S. S. (2004). Protein Kinase C-{alpha} Activity Is Required for Respiratory Syncytial Virus Fusion to Human Bronchial Epithelial Cells. J. Virol. 78: 13717-13726 [Abstract] [Full Text]  
  • Budge, P. J., Graham, B. S. (2004). Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding viruses. J Antimicrob Chemother 54: 299-302 [Abstract] [Full Text]  
  • Elliott, M. B., Pryharski, K. S., Yu, Q., Parks, C. L., Laughlin, T. S., Gupta, C. K., Lerch, R. A., Randolph, V. B., LaPierre, N. A., Dack, K. M. H., Hancock, G. E. (2004). Recombinant Respiratory Syncytial Viruses Lacking the C-Terminal Third of the Attachment (G) Protein Are Immunogenic and Attenuated In Vivo and In Vitro. J. Virol. 78: 5773-5783 [Abstract] [Full Text]  
  • Budge, P. J., Li, Y., Beeler, J. A., Graham, B. S. (2004). RhoA-Derived Peptide Dimers Share Mechanistic Properties with Other Polyanionic Inhibitors of Respiratory Syncytial Virus (RSV), Including Disruption of Viral Attachment and Dependence on RSV G. J. Virol. 78: 5015-5022 [Abstract] [Full Text]  
  • Easton, A. J., Domachowske, J. B., Rosenberg, H. F. (2004). Animal Pneumoviruses: Molecular Genetics and Pathogenesis. Clin. Microbiol. Rev. 17: 390-412 [Abstract] [Full Text]  
  • Escribano-Romero, E., Rawling, J., Garcia-Barreno, B., Melero, J. A. (2004). The Soluble Form of Human Respiratory Syncytial Virus Attachment Protein Differs from the Membrane-Bound Form in Its Oligomeric State but Is Still Capable of Binding to Cell Surface Proteoglycans. J. Virol. 78: 3524-3532 [Abstract] [Full Text]  
  • Zhang, Y., Rassa, J. C., deObaldia, M. E., Albritton, L. M., Ross, S. R. (2003). Identification of the Receptor Binding Domain of the Mouse Mammary Tumor Virus Envelope Protein. J. Virol. 77: 10468-10478 [Abstract] [Full Text]  
  • Douglas, J. L., Panis, M. L., Ho, E., Lin, K.-Y., Krawczyk, S. H., Grant, D. M., Cai, R., Swaminathan, S., Cihlar, T. (2003). Inhibition of Respiratory Syncytial Virus Fusion by the Small Molecule VP-14637 via Specific Interactions with F Protein. J. Virol. 77: 5054-5064 [Abstract] [Full Text]  
  • Schlender, J., Zimmer, G., Herrler, G., Conzelmann, K.-K. (2003). Respiratory Syncytial Virus (RSV) Fusion Protein Subunit F2, Not Attachment Protein G, Determines the Specificity of RSV Infection. J. Virol. 77: 4609-4616 [Abstract] [Full Text]  
  • Zimmer, G., Conzelmann, K.-K., Herrler, G. (2002). Cleavage at the Furin Consensus Sequence RAR/KR109 and Presence of the Intervening Peptide of the Respiratory Syncytial Virus Fusion Protein Are Dispensable for Virus Replication in Cell Culture. J. Virol. 76: 9218-9224 [Abstract] [Full Text]  
  • Zhang, L., Peeples, M. E., Boucher, R. C., Collins, P. L., Pickles, R. J. (2002). Respiratory Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized, Specific to Ciliated Cells, and without Obvious Cytopathology. J. Virol. 76: 5654-5666 [Abstract] [Full Text]  
  • Gorman, J. J., McKimm-Breschkin, J. L., Norton, R. S., Barnham, K. J. (2001). Antiviral Activity and Structural Characteristics of the Nonglycosylated Central Subdomain of Human Respiratory Syncytial Virus Attachment (G) Glycoprotein. J. Biol. Chem. 276: 38988-38994 [Abstract] [Full Text]  
  • Hurrelbrink, R. J., McMinn, P. C. (2001). Attenuation of Murray Valley Encephalitis Virus by Site-Directed Mutagenesis of the Hinge and Putative Receptor-Binding Regions of the Envelope Protein. J. Virol. 75: 7692-7702 [Abstract] [Full Text]  
  • Techaarpornkul, S., Barretto, N., Peeples, M. E. (2001). Functional Analysis of Recombinant Respiratory Syncytial Virus Deletion Mutants Lacking the Small Hydrophobic and/or Attachment Glycoprotein Gene. J. Virol. 75: 6825-6834 [Abstract] [Full Text]  
  • Zimmer, G., Trotz, I., Herrler, G. (2001). N-Glycans of F Protein Differentially Affect Fusion Activity of Human Respiratory Syncytial Virus. J. Virol. 75: 4744-4751 [Abstract] [Full Text]  
  • Zimmer, G., Budz, L., Herrler, G. (2001). Proteolytic Activation of Respiratory Syncytial Virus Fusion Protein. CLEAVAGE AT TWO FURIN CONSENSUS SEQUENCES. J. Biol. Chem. 276: 31642-31650 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»